Careers  |  Sign In  |  Register  |   Twitter

FDA Approves Urolift for Urinary Problems in Men

The Washington Post reports that the FDA has issued approval of the first permanent implant to treat urinary problems that are often caused by an enlarged prostate. The implant, called Urolift, “works by holding back prostate tissue that presses against the urethra, causing difficulty urinating.” It is implanted through the urethra and can now take the place of traditional treatment options such as surgery or drug therapy. The implant is thought to help with “frequent urination, weak stream, and leaking,” from which approximately 50% of men in their 60s suffer.

Read it in The Washington Post.

Read the FDA News Release.